MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Magnetic Property Characterization of Deep Gray Matters in Patients with Alzheimer’s diseases, Dementia with Lewy Bodies and Parkinson’s Disease Dementia using Quantitative Susceptibility Mapping

    J. Kim, K. Lee, S. Yoo, Y. Oh, S. Koh (Seoul, Republic of Korea)

  • Maintenance of safinamide 100 mg daily long-term

    N. FONCEA (Galdakao, Spain)

  • Maladaptive motor cortex plasticity off medication in Parkinson’s disease patients with levodopa-induced dyskinesias

    M. Dileone, C. Ammann, V. Catanzaro, R. Piredda, M.G Monje, I. Navalpotro-Gómez, A. Bergareche, L. Vela, F. Alonso-Frech, M.J Catalán-Alonso, J.A Molina, N. López-Ariztegui, F. Hernández-Fernández, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, A. Sánchez-Ferro, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)

  • Maladaptive use of LD/CD tablets as painkillers causing Dopamine Dysregulation Syndrome in 4 patients of Advanced Parkinson’s Disease

    M. Gautam, K. Shukla, N. Sawal (Chandigarh, India)

  • Male-specific exacerbation of susceptibility to α-synuclein pre-formed fibrils by developmental dieldrin exposure in mice

    A. Gezer, J. Kochmanski, S. VanOeveren, A. Cole-Strauss, C. Kemp, J. Patterson, K. Miller, N. Kuhn, D. Herman, A. McIntire, J. Lipton, K. Luk, S. Fleming, C. Sortwell, A. Bernstein (Grand Rapids, MI, USA)

  • Management of Cervical Dystonia & Spastic Paresis with Botulinum Neurotoxin-A: results from the INPUT survey

    R. Bhidayasiri, L.J Jacinto, K. Bhatia, N. Dursun, T.M Chung, J. Tiley, C. Colosimo (Bangkok, Thailand)

  • Management of Dystonia in Europe from Patients’ Experience

    M. Relja, V. Miletic (Zagreb, Croatia)

  • Management of neuropsychiatric symptoms in Parkinson’s disease (PD) at the front door

    M.A Farooqi, A. Chatterjee (Reading, United Kingdom)

  • Management of parkinsonian patients with long-term DBS and incomplete control of symptoms

    I. Reuter (Giessen, Germany)

  • Management practices and long-term follow up of pediatric functional (psychogenic) movement disorder at a tertiary care center

    M. Hull, J.M Maldonado-Duran, M. Parnes (Houston, TX, USA)

  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley